Shareholding disclosure

Biotech Invest N.V., -Curacao, Niederländische Antillen

Declared position

5.2%

Threshold

Crossed upwards

Timeline

Published

10.01.2002

Transaction

—

Voting rights breakdown

Voting rights acquired5.2%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T1294D1264

Beneficial owner

Biotech Invest N.V., -Curacao, Niederländische Antillen

Declared address

Biotech Invest N.V., Curacao, Niederländische Antillen, Curacao

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Biotech Invest N.V., -Curacao, Niederländische Antillen

Actelion Ltd10.01.2002T1294D1264

Disclosure summary

Biotech Invest N.V., -Curacao, Niederländische Antillen disclosed a holding in Actelion Ltd on the acquisition side, published by SIX Exchange Regulation on 10.01.2002, at 5.2% of voting rights. Notice category: Group of shareholders.

Disclosed position

5.2%

Voting rights acquired

Voting rights acquired5.2%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Biotech Invest N.V., -Curacao, Niederländische Antillen disclosed a holding in Actelion Ltd, published on 10.01.2002.

Publication date10.01.2002

Issuing companyActelion Ltd

Beneficial ownerBiotech Invest N.V., -Curacao, Niederländische Antillen

Declared addressBiotech Invest N.V., Curacao, Niederländische Antillen, Curacao

CategoryGroup of shareholders

Voting rights acquired5.2%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT1294D1264

Source: SIX Exchange Regulation · Publication date: 10.01.2002

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open